STOCK TITAN
  1. Home
  2. Sec-filings
  3. CGON
  4. [144] CG Oncology, Inc. Common stock SEC Filing

[144] CG Oncology, Inc. Common stock SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CGON logo
CG Oncology, Inc.

NASDAQ:CGON

CGON Rankings

#2744 Ranked by Market Cap
N/A Ranked by Dividends

CGON Latest News

Jun 5, 2025
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 15, 2025
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
May 13, 2025
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
May 1, 2025
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
Apr 26, 2025
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CGON Latest SEC Filings

Jul 18, 2025
[Form 4] CG Oncology, Inc. Common stock Insider Trading Activity
Jul 11, 2025
[8-K] CG Oncology, Inc. Common stock Reports Material Event

CGON Stock Data

2.07B
69.01M
6.28%
100.1%
9.19%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
IRVINE